ClinicalTrials.govpublic full text
A Phase I Study of ABT-888 in Combination With Temozolomide in Cancer Patients
non-hematologic malignancies, metastatic melanoma, breast cancer, ovarian cancer, primary peritoneal cancer, fallopian tube cancer, hepatocellular carcinoma, solid tumor, melanoma, hcc, brca deficient, brca mutation
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 872283
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.